- Did you mean
- sans-cov-2
Search results - 240 results
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.
COVID-19 Humans SARS-CoV-2 Sensitivity and Specificity Seroepidemiologic Studies Serologic Tests Abstract: OBJECTIVES: Assess the performance of five SARS-CoV-2 rapid serological tests (RST) using finger ...
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
Humans SARS-CoV-2 vaccines Abstract: In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their vaccination status. We estimated vaccine effectiveness (VE) against ...
L’épidémiologie de l’affection post-Covid-19 en Belgique
participants (n = 2.092) déclaraient avoir au moins un symptôme lié à leur infection au SARS-CoV-2 trois mois après celle-ci, mais sans nécessairement toujours déclarer un moins bon état de santé. Environ 30% ...
De epidemiologie van long covid in België
twee jaar (april 2021 — april 2023), uitgevoerd bij volwassenen die een SARS-CoV-2-infectie hadden opgelopen. 47% van de patiënten (n = 2.092) gaf aan dat ze drie maanden na de SARS-CoV-2-infectie nog ...
Real-World Comparative Effectiveness of SARS-CoV-2 Primary Vaccination Campaigns Against SARS-CoV-2 Infections: A Federated Observational Study Emulating a Target Trial in Three Nations
Bernal-Delgado Source: The Lancet, Elsevier BV (2024) Keywords: Cohort Studies COVID-19 Electronic Health Records Humans Kaplan-Meier Estimate prevention & control SARS-CoV-2 Vaccine Efficacy Viral Vaccines ...
EQA Mol bio Micro- Global report- 2023-Q7 (SARS-COV2 D)
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Source: (0) Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories Efficacité et sécurité des vaccins, ...
Monitoring of the immune response to SARS-CoV-2 in vulnerable populations: the COVICO study (2023-2026)
Publication Type: Scientific poster, presentation or proceeding Authors: Alexia Charles; Stéphanie Depickère; Delphine Kemlin; Isabelle Etienne; Nicolas Gemander; Leen Vandermosten; Mathieu Verbrugghe; Isabelle Maufort; Léo Hendrickx; Pieter Pannus; Véron ...
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Hospitalization Humans Male SARS-CoV-2 Vaccination Vaccine Efficacy Abstract: BACKGROUND: We aimed to estimate XBB.1.5 vaccine effectiveness (VE) against COVID-19-related hospitalizations and deaths during BA.2.86/ ...
Surveillance des infections respiratoires aiguës. Rapport épidémiologique des saisons 2020-2022
Abstract: La saison 2020-2021 fut marquée par les 2e et 3e vagues de la pandémie de COVID-19, pendant lesquelles le variant Alpha fut dominant. La transmission du Sars-Cov-2 et les hospitalisations pour ...
Surveillance van acute luchtweginfecties. Epidemiologisch rapport seizoen 2020-2022
Abstract: Het seizoen 2020-2021 werd gekenmerkt door de 2e en 3e golf van de COVID-19-pandemie, waarin de alpha-variant dominant was. SARS-Cov-2 transmissie en ziekenhuisopnames voor COVID-19 waren bijzonder ...